Viemed Q1 2023 revenue record $39.6M, up 31% YoY; EBITDA $8.3M

VIEMED HEALTHCARE, INC.

2023-Q1 EPS reported $0.04 revenue$39,556,000

Net revenue of $39.6M, a record, up 31% from Q1 2022 and 6% sequentially.
Net income of $1.5M; adjusted EBITDA of $8.3M, up 15% from Q1 2022.
Prior-year quarter benefited from COVID-related revenue and Provider Relief Fund income.
No specific EPS or guidance provided in the press release excerpt.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

VIEMED HEALTHCARE, INC. reported three months ended March 31, 2023 results: revenue $39.6 million, net income $1.5 million.

Period: three months ended March 31, 2023
Revenue: $39.6 million
Net income: $1.5 million
Result: reported results

Exact text from the filing

Operational highlights (all dollar amounts are USD): • Net revenues attributable to the Company's core business for the quarter ended March 31, 2023 were $39.6 million, a new Company record, and an increase of $9.4 million, or 31%, over the quarter ended March 31, 2022. Net revenues for the quarter ended March 31, 2023 were up approximately 6% over the quarter ended December 31, 2022. • Net income for the quarter ended March 31, 2023 totaled $1.5 million.

View on SEC.gov

Browse all earnings releases →

VIEMED HEALTHCARE, INC. filing history →

Source: SEC EDGAR

accession 0001729149-23-000061

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.